Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 599, Issue 1-2, 2006, Pages 124-134

  Dianzani, I ^a,b   Gibello, L ^a   Biava, A ^a   Giordano, M ^a   Bertolotti, M ^a   Betti, M ^a   Ferrante, D ^a   Guarrera, S ^b   Betta, G P ^c   Mirabelli, D ^a,b   Matullo, G ^b   Magnani, C ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c C Arrigo Children's Hospital   (Italy)

Author keywords

Asbestos; DNA repair genes; Genetic polymorphisms; Malignant mesothelioma

Indexed keywords

ASBESTOS; DNA GLYCOSYLTRANSFERASE; PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 3; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

AGED; ARTICLE; ASBESTOSIS; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MUTAGENESIS; OCCUPATIONAL EXPOSURE; POLLUTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL;

AGED; ASBESTOS; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA PRIMERS; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; ITALY; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 33745895624     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.02.005     Document Type: Article

References (57)

1. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup. Environ. Med. 56 (1999) 505-513
2. Jensen C.G., Jensen L.C.W., Rieder C.L., Cole R.W., and Ault J.C. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 17 (1996) 2013-2021
3. Chen Q., Marsh J., Ames B., and Mossman B.T. Detection of 8-oxo-2′-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. Carcinogenesis 17 (1996) 2525-2527
4. Fung H., Kow Y.W., Van Houten B., and Mossman B.T. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 18 (1997) 825-832
5. Wang D., Kreutzer D.A., and Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 400 (1998) 99-115
6. Marczynski B., Rozynek P., Kraus T., Schlosser St., Raithel H.J., and Baur X. Levels of 8-hydroxy-2′-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat. Res. 468 (2000) 195-202
7. Bianchi C., Giarelli L., Grandi G., Brollo A., Ramani L., and Zuch C. Latency periods in asbestos-related mesothelioma of the pleura. Eur. J. Cancer Prev. 6 (1997) 162-166
8. Ascoli V., Scalzo C.C., Bruno C., Facciolo F., Lopergolo M., Granone P., and Nardi F. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 130 (1998) 203-207
9. Roushdy-Hammady I., Siegel J., Emri S., Testa J.R., and Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 357 (2001) 444-445
10. Hirvonen A., Pelin K., Tammilehto L., Karjalainen A., Mattson K., and Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos related human malignant mesothelioma. Cancer Res. 55 (1995) 2981-2983
11. Neri M., Filiberti R., Taioli E., Garte S., Paracchini V., Bolognesi C., Canessa P.A., Fontana V., Ivaldi G.P., Verna A., Bonassi S., and Puntoni R. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat. Res. (2005) June 30 [Epub ahead of print]
12. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology 181/182 (2002) 457-462
13. Bolognesi C., Martini F., Tognon M., Filiberti R., Neri M., Perrone E., Landini E., Canessa P.A., Ivaldi G.P., Betta G.P., Mutti L., and Puntoni R. A molecular epidemiology case control study on pleural malignant mesothelioma. Cancer Epidemiol. Biomark. Prev. 14 (2005) 1741-1746
14. Bolognesi C., Filiberti R., Neri M., Perrone E., Landini E., Canessa P.A., Simonassi C., Cerrano P.G., Mutti L., and Puntoni R. High frequency of micronuclei in peripheral blood lymphocytes as index of susceptibility to pleural malignant mesothelioma. Cancer Res. 62 (2002) 5418-5419
15. Matullo G., Guarrera S., Carturan S., Peluso M., Malaveille C., Davico L., Piazza A., and Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int. J. Cancer 92 (2001) 562-567
16. Cho E.Y., Hildesheim A., Chen C.J., Hsu M.M., Chen I.H., Mittl B.F., Levine P.H., Liu M.Y., Chen J.Y., Brinton L.A., Cheng Y.J., and Yang C.S. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1100-1104
17. Yu M.W., Yang S.Y., Pan I.J., Lin C.L., Liu C.J., Liaw Y.F., Lin S.M., Chen P.J., Lee S.D., and Chen C.J. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 95 (2003) 1485-1488
18. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., Munnia A., Matullo G., and Peluso M. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer 94 (2001) 121-127
19. Duell E.J., Wiencke J.K., Cheng T.-J., Varkonyi A., Zuo Z.F., Ashok T.D.S., Mark E.J., Wain J.C., Christiani D.C., and Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21 (2000) 965-971
20. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59 (1999) 2557-2561
21. Sugimura H., Kohno T., Wakai K., Nagura K., Genka K., Igarashi H., Morris B.J., Baba S., Ohno Y., Gao C., Li Z., Wang J., Takezaki T., Tajima K., Varga T., Sawaguchi T., Lum J.K., Martinson J.J., Tsugane S., Iwamasa T., Shinmura K., and Yokota J. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomark. Prev. 8 (1999) 669-674
22. Hung J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Chabrier A., Borel S., Hall J., and Boffetta P. Large-scale investigation of base excision repair genetic polymorphism and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 97 (2005) 567-576
23. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., and Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22 (2001) 1437-1445
24. Matullo G., Guarrera S., Sacerdote C., Polidoro S., Davico L., Gamberini S., Karagas M., Casetta G., Rolle L., Piazza A., and Vineis P. Polymorphisms/haplotypes in DNA repair Genes and Smoking: A Bladder Cancer Case-Control Study. Cancer Epidemiol. Biomark. Prev. 14 (2005) 2569-2578
25. Jacobsen N.R., Raaschou-Nielsen O., Nexo B., Wallin H., Overvad K., Tjonneland A., and Vogel U. XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 213 (2004) 67-72
26. Magnani C., Dalmasso P., Biggeri A., Ivaldi C., Mirabelli D., and Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos. A case-control study in Casale Monferrato-Italy. Env. Health Persp. 109 (2001) 915-919
27. Magnani C., Agudo A., Gonzalez C.A., Andrion A., Calleja A., Chellini E., Dalmasso P., Escolar A., Hernandez S., Ivaldi C., Mirabelli D., Ramirez J., Turuguet D., Usel M., and Terracini B. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br. J. Cancer 83 (2000) 104-111
28. Bjorkqvist A.M., Wolf M., Nordling S., Tammilehto L., Knuuttila A., Kere J., Mattson K., and Knuutila S. Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis. Br. J. Cancer 81 (1999) 1111-1115
29. Shigemitsu K., Sekido Y., Usami N., Mori S., Sato M., Horio Y., Hasegawa Y., Bader S.A., Gazdar A.F., Minna J.D., Hida T., Yoshioka H., Imaizumi M., Ueda Y., Takahashi M., and Shimokata K. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene 20 (2001) 4249-4257
30. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.-R., Sugimura H., Nohmi T., Kasai H., and Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16 (1998) 3219-3225
31. Yamane A., Kohno T., Ito K., Sunaga N., Aoki K., Yoshimura K., Murakami H., Nojima Y., and Yokota J. Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 25 (2004) 1689-1694
32. Hoogendoorn B., Owen M.J., Oefner P.J.N., Williams N., Austin J., and O'Donovan M.C. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum. Genet. 104 (1999) 89-93
33. Matullo G., Dunning A.M., Guarrera S., Baynes C., Polidoro S., Garte S., Autrup H., Malaveille C., Peluso M., Airoldi L., Veglia F., Gormally E., Hoek G., Krzyzanowski M., Overvad K., Raaschou-Nielsen O., Clavel-Chapelon F., Linseisen J., Boeing H., Trichopoulou A., Palli D., Krogh V., Tumino R., Panico S., Bueno-De-Mesquita H.B., Peeters P.H., Lund E., Pera G., Martinez C., Dorronsoro M., Barricarte A., Tormo M.J., Quiros J.R., Day N.E., Key T.J., Saracci R., Kaaks R., Riboli E., and Vineis P. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. (2005) November 23 [Epub ahead of print]
34. N.E. Breslow, N.E. Day. Statistical Methods in Cancer Research, vol I. The Design and Analysis of Case-control Studies. IARC Sci. Publ. 32, IARC, Lyon, 1980.
35. Wacholder S., Chanock S., Garcia-Closas M., El ghormli L., and Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 96 (2004) 434-442
36. Nilsen H., and Krokan H.E. Base excision repair in a network of defence and tolerance. Carcinogenesis 22 (2001) 987-998
37. Whitehouse C.J., Taylor R.M., Thistlethwaite A., Zhang H., Karimi-Busheri F., Lasko D.D., Weinfeld M., and Caldecott K.W. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104 (2001) 107-117
38. Vidal A.E., Boiteux S., Hickson I.D., and Radicella J.P. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interaction. EMBO J. 20 (2001) 6530-6539
39. Marsin S., Vidal A.E., Sossou M., Menissier-de Murcia J., Le Page F., Boiteux S., de Murcia G., and Radicella J.P. Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J. Biol. Chem. 278 (2003) 44068-44074
40. Hu J.J., Smith T.R., Miller M.S., Mohrenweiser H.W., Golden A., and Case L.D. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22 (2001) 917-922
41. Taylor R.M., Thistlethwaite A., and Caldecott K.W. Central role for the XRCC1 BRCT 1 domain in mammalian DNA single-strand break repair. Mol. Cell Biol. 22 (2002) 2256-2263
42. Sturgis E.M., Castilli E.J., Li L., Zheng R., Eicher S.A., Clayman G.L., Strom S.S., Spitz M.R., and Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and the neck. Carcinogenesis 20 (1999) 2125-2129
43. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L., Wang X., Spitz M.R., and Wei Q. Polymorphisms of DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer 88 (2000) 601-606
44. Divine K.K., Gilliland F.D., Crowell R.E., Stidley C.A., Bocklage T.J., Cook D.L., and Belinsky S.A. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat. Res. 461 (2001) 273-278
45. Ito H., Matsuo K., Hamajima N., Mitsudomi T., Sugiura T., Saito T., Yasue T., Lee K.M., Wang D., Yoo K.Y., Sato S., Ueda R., and Tajima K. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25 (2004) 1395-1401
46. Park J.Y., Lee S.Y., Jeon H.-S., Bae N.C., Chae S.C., Joo S., Kim C.H., Park J.H., Kam S., Kim I.S., and Jung T.H. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol. Biomark. Prev. 11 (2002) 23-27
47. Stern M.C., Umbach D.M., Lunn R.M., and Taylor J.A. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol. Biomark. Prev. 11 (2002) 939-943
48. Duell E.J., Millikan R.C., Pittman G.S., Winkel S., Lunn R.M., Tse C.K., Eaton A., Mohernweiser H.W., Newman B., and Bell D.A. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomark. Prev. 10 (2001) 217-222
49. Han J., Hankinson S.E., De Vivo I., Spiegelman D., Tamimi R.M., Mohrenweiser H.W., Colditz G.A., and Hunter D.J. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res. 63 (2003) 8536-8541
50. Smith T.R., Levine E.A., Perrier N.D., Miller M.S., Freimanis R.I., Lohman K., Case L.D., Xu J., Mohrenweiser H.W., and Hu J.J. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1200-1204
51. Figueiredo J.C., Knight J.A., Briollais L., Andrulis I.L., and Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the breast cancer family registry. Cancer Epidemiol. Biomark. Prev. 13 (2004) 583-591
52. Shu X.O., Cai Q., Gao Y.T., Wen W., Jin F., and Zheng W. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1462-1467
53. Rybicki B.A., Conti D.V., Moreira A., Cicek M., Casey G., and Witte J.S. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol. Biomark. Prev. 13 (2004) 23-29
54. Matsuo K., Hamajima N., Suzuki R., Andoh M., Nakamura S., Seto M., Morishimae Y., and Tajima K. Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan. Cancer Genet. Cytogenet. 149 (2004) 77-80
55. Varzim G., Monteiro E., Silva R.A., Fernandes J., and Lopes C. CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur. J. Cancer Prev. 12 (2003) 495-499
56. Shen M., Hung R.J., Brennan P., Malaveille C., Donato F., Placidi D., Carta A., Hautefeuille A., Boffetta P., and Porru S. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomark. Prev. 12 (2003) 1234-1240
57. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1513-1530